Unicycive Therapeutics (UNCY) Enterprise Value (2021 - 2026)
Unicycive Therapeutics posted quarterly Enterprise Value of -$54.6 million for Q1 2026, down 176.12% year-on-year from $71.7 million in Q1 2025, and down 32.27% on a QoQ basis from -$41.3 million in Q4 2025.
Unicycive Therapeutics (UNCY) has 6 years of Enterprise Value data on file, last reported at -$54.6 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 176.12% year-over-year to -$54.6 million; the trailing twelve-month figure through Mar 2026 stood at -$54.6 million (down 176.12% YoY), and the FY2025 full-year result was -$41.3 million, down 57.86% from the prior year.
- Enterprise Value for Q1 2026 stood at -$54.6 million, down from -$41.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$455000.0 in Q4 2022 and bottomed at -$54.6 million in Q1 2026.
- The 5-year median for Enterprise Value is -$22.3 million (2025), against an average of -$25.2 million.
- Peak annual rise in Enterprise Value reached 97.26% in 2022, while the deepest fall reached 1057200.0% in 2022.
- A 5-year view of Enterprise Value shows it stood at -$455000.0 in 2022, then plunged by 2032.09% to -$9.7 million in 2023, then sank by 169.48% to -$26.1 million in 2024, then tumbled by 57.86% to -$41.3 million in 2025, then tumbled by 32.27% to -$54.6 million in 2026.
- The last three Enterprise Value figures came in at -$54.6 million (Q1 2026), -$41.3 million (Q4 2025), and -$42.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Unicycive Therapeutics | 181.94 Mn | 127.36 Mn | - | -54.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.59 Mn |
| Dec 31, 2025 | -41.27 Mn |
| Sep 30, 2025 | -42.70 Mn |
| Jun 30, 2025 | -22.33 Mn |
| Mar 31, 2025 | -19.77 Mn |
| Dec 31, 2024 | -26.14 Mn |
| Sep 30, 2024 | -32.35 Mn |
| Jun 30, 2024 | -41.78 Mn |
| Mar 31, 2024 | -48.93 Mn |
| Dec 31, 2023 | -9.70 Mn |
| Sep 30, 2023 | -14.35 Mn |
| Jun 30, 2023 | -18.82 Mn |
| Mar 31, 2023 | -24.33 Mn |
| Dec 31, 2022 | -455,000.00 |
| Sep 30, 2022 | -7.01 Mn |
| Jun 30, 2022 | -10.57 Mn |
| Mar 31, 2022 | -13.62 Mn |
| Dec 31, 2021 | -16.58 Mn |
| Sep 30, 2021 | -18.01 Mn |
| Jun 30, 2021 | -1,000.00 |